Healthcare Sales & Marketing Network News: ischemic stroke

Searching News Database: ischemic stroke

HSMN NewsFeed - 1 Jun 2023
NeuroTrauma Sciences Commences First-in-Human Dosing in the US of Investigational Neuroprotective Drug NTS-104
Biopharmaceuticals Neurology Drug Delivery

HSMN NewsFeed - 31 Jan 2023
MicroTransponder Secures CMS Transitional Pass-Through Status & New Technology Add-On Payment for Its Breakthrough Stroke Rehabilitation System, Vivistim
Devices Neurology Reimbursement

HSMN NewsFeed - 27 Jan 2023
Infinity Neuro Receives CE Mark Approval for Their First Device to Treat Stroke
Devices Interventional Neurology Regulatory

HSMN NewsFeed - 13 Sep 2022
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
Devices Interventional Neurology Venture Capital

HSMN NewsFeed - 10 May 2022
Magneto Thrombectomy Solutions Announces Successful First-in-Human Results for Treatment of Pulmonary Embolism (PE)
Devices Interventional

HSMN NewsFeed - 28 Apr 2022
Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer(TM) Steerable Delivery Sheath for the Company's Amulet(TM) Device
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 21 Apr 2022
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
Devices Interventional Acquisitions

HSMN NewsFeed - 31 Aug 2021
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
Devices Neurology FDA

HSMN NewsFeed - 16 Aug 2021
Abbott's Amplatzer(TM) Amulet(TM) Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke
Devices Interventional Cardiology FDA

HSMN NewsFeed - 24 May 2021
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Regenerative Medicine Licensing

HSMN NewsFeed - 21 Jan 2021
MIVI Neuroscience Secures Series B Funding
Devices Interventional Neurology Venture Capital

HSMN NewsFeed - 24 Nov 2020
Elevian Announces $15 Million Equity Financing
Biopharmaceuticals Regenerative Medicine Venture Capital

HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 27 Jul 2020
Rapid Medical Receives CE Mark for TIGERTRIEVER(TM) XL
Devices Interventional Neurology Regulatory

HSMN NewsFeed - 14 May 2020
U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa(R) for Third Year
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 6 May 2020
FDA Clears New Mechanical Thrombectomy Platform
Devices Interventional FDA

HSMN NewsFeed - 7 Apr 2020
Portola Pharmaceuticals Announces the Establishment of a Permanent J-code for Andexxa by the Centers for Medicare & Medicaid Services, Effective July 1, 2020
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 7 Apr 2020
Rapid Medical Announces Ahead of Schedule Completion of Patient Enrollment for the TIGER Clinical Study for TIGERTRIEVER Thrombectomy Device
Devices Interventional Radiology Neurology

HSMN NewsFeed - 5 Mar 2020
New Data Demonstrates Andexxa(R) Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with Oral Factor Xa Inhibitors
Biopharmaceuticals

HSMN NewsFeed - 21 Oct 2019
Perflow Medical Receives CE Mark Approval of Novel Cascade(TM) Agile
Devices Neurology Interventional Regulatory

HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory

HSMN NewsFeed - 4 Jun 2019
GORE(R) CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects
Devices Interventional Cardiology FDA

HSMN NewsFeed - 7 May 2019
Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device
Devices Interventional FDA

HSMN NewsFeed - 29 Apr 2019
New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events in Adults with No Known Heart Disease
Diagnostics Cardiology

HSMN NewsFeed - 12 Sep 2018
FDA to Review Supplemental Biologics License Application for Praluent(R) (alirocumab)Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 27 Aug 2018
Janssen Announces Results from MARINER and COMMANDER HF Studies
Biopharmaceuticals Cardiology

HSMN NewsFeed - 12 Jun 2018
MicroVention Announces FDA Clearance For Thrombectomy Device
Devices Interventional Neurology FDA

HSMN NewsFeed - 21 May 2018
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
Devices Interventional Radiology Neurology FDA

HSMN NewsFeed - 3 Apr 2018
FDA Approves GORE(R) CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
Devices Interventional Cardiology FDA

HSMN NewsFeed - 15 Feb 2018
Perflow Medical Closes $12 Million in Financing to Treat Complex Neurovascular Disorders
Devices Interventional Neurology Venture Capital

HSMN NewsFeed - 11 Jan 2018
First Patient Enrolled in U.S. IDE Study To Evaluate the Potential of New Device To Reduce Stroke Risk in Atrial Fibrillation Patients
Devices Interventional Cardiology

HSMN NewsFeed - 7 Sep 2017
Johnson & Johnson Medical Devices Companies Signals Commitment to Stroke Treatment With the Announcement of New Neurovascular Business
Devices Neurology Interventional

HSMN NewsFeed - 18 Jul 2017
Silk Road Medical Announces $47 Million Financing led by Norwest Venture Partners and Funds Managed by Janus Capital Management LLC
Devices Interventional Radiology Venture Capital

HSMN NewsFeed - 17 Jul 2017
Sensome, Formerly Instent, Raises �4.7m to Bring the World's First Connected Stroke Guidewire to Patients
Devices Interventional Venture Capital

HSMN NewsFeed - 10 Apr 2017
Codman Neuro Announces Acquisition Of Neuravi Limited To Accelerate Innovation In Acute Ischemic Stroke Therapy
Devices Neurology Interventional Mergers & Acquisitions

HSMN NewsFeed - 3 Feb 2017
Amgen Announces Repatha(R) (Evolocumab) Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 Nov 2016
Neural Analytics Announces Commercial Launch of Lucid(TM) M1 Transcranial Doppler Ultrasound System at 9th Annual Society of Vascular and Interventional Neurology Meeting
Devices Monitoring Neurology Product Launch

HSMN NewsFeed - 15 Nov 2016
Portola Pharmaceuticals Announces Three Phase 3 APEX Substudy Results Showing Further Benefits of Treating Acute Medically Ill Patients with Extended-Duration Betrixaban
Biopharmaceuticals

HSMN NewsFeed - 14 Nov 2016
Technopath Clinical Diagnostics Launches its First Diagnostic Reagent Product, the i-plaq(TM) Test for Lp-PLA2
Diagnostics Cardiology Product Launch

HSMN NewsFeed - 8 Sep 2016
Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke
Devices Neurology Interventional Product Launch

HSMN NewsFeed - 25 Jul 2016
Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever
Devices Interventional Neurology Personnel

HSMN NewsFeed - 5 Jul 2016
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 20 May 2016
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
Regenerative Medicine Neurology

HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 5 Nov 2015
Neuravi Announces First Patient Treated in International Pivotal Clinical Trial of Novel Stent Retriever for Acute Ischemic Stroke
Devices Neurosurgery Interventional

HSMN NewsFeed - 17 Jun 2015
Neuravi Announces �19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy
Devices Neurology Interventional Venture Capital

HSMN NewsFeed - 17 Apr 2015
Global Trials Show Addition of Medtronic�s Solitaire(TM) Device Stent Thrombectomy Procedure in Treatment of Acute Ischemic Stroke Improves Neurological Outcomes
Devices Interventional Neurology

HSMN NewsFeed - 13 Mar 2015
Boston Scientific Receives FDA Approval for WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Cardiology FDA

HSMN NewsFeed - 20 Aug 2014
Advanced Catheter Therapies Announces Series B Equity Financing
Devices Venture Capital

HSMN NewsFeed - 23 Jun 2014
New Philips NeuroSuite Reveals the Brain's Vascular Network like Never Before
Devices Neurology Interventional Radiology

HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 1 May 2014
BOTOX(R) (Botulinum Toxin Type A) Receives a Positive Opinion in Fourteen European Countries for the Treatment of Focal Spasticity of the Ankle in Adult Post Stroke Patients
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Feb 2014
BOTOX(R) (Botulinum toxin type A) Receives Approval in the UK for the Treatment of Ankle Disability due to Lower Limb Spasticity Associated with Stroke in Adults
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 14 Jan 2014
Neuralstem Appoints Catherine Angell Sohn To Board Of Directors
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 13 Jan 2014
U.S. FDA Approves Farxiga(TM) (Dapagliflozin) Tablets for the Treatment of Adult Patients with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 5 Dec 2013
Tyrosine Pharma Names Laslie President and CEO
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 19 Nov 2013
AtriCure Receives FDA Approval for Investigational Study to Evaluate Stroke Prevention in Atrial Fibrillation
Devices Cardiology FDA

HSMN NewsFeed - 5 Sep 2013
Neuralstem To Raise $4 Million In Registered Direct Offering
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 30 Aug 2013
Jan Medical Announces Corporate Collaboration With, and Further Investment By, Brainlab
Devices Neurosurgery Monitoring Venture Capital

HSMN NewsFeed - 22 Aug 2013
diaDexus, Inc. Appoints Ralf Schoenbrunner to Senior Vice President, Research and Early Development
Diagnostics Cardiology Personnel

HSMN NewsFeed - 19 Apr 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
Regenerative Medicine Neurology Licensing

HSMN NewsFeed - 18 Mar 2013
Cytomedix Announces Centers for Medicare & Medicaid Services (CMS) Issuance Of Reimbursement Coding for Autologous PRP in Chronic Non-Healing Wounds
Regenerative Medicine Wound Care Reimbursement

HSMN NewsFeed - 8 Mar 2013
St. Jude Medical Announces First Implant in Pivotal Phase of Clinical Trial Evaluating AMPLATZER Cardiac Plug for the Prevention of Stroke in Patients with Atrial Fibrillation
Devices Interventional Cardiology

HSMN NewsFeed - 8 Feb 2013
Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013
Devices Interventional Cardiology

HSMN NewsFeed - 18 Jan 2013
St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention
Devices Cardiology Regulatory

HSMN NewsFeed - 14 Jan 2013
SanBio Announces Enrollment Of The Second Cohort Of Patients In Its Clinical Trial Of Stem Cell Therapy For Chronic Stroke
Regenerative Medicine Neurology

HSMN NewsFeed - 14 Jan 2013
Neuralstem Receives FDA Approval To Commence Spinal Cord Injury Trial
Biopharmaceuticals Regenerative Medicine Neurology FDA

HSMN NewsFeed - 14 Jan 2013
Covidien Opens Patient Enrollment for SWIFT PRIME Acute Ischemic Stroke Study
Devices Neurology Interventional

HSMN NewsFeed - 26 Dec 2012
ELIQUIS(R) (apixaban) Approved In Japan For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 13 Dec 2012
Covidien�s Solitaire(TM) FR Revascularization Device Receives Regulatory Approval in Canada
Devices Interventional Neurology Regulatory

HSMN NewsFeed - 29 Nov 2012
Cytomedix Announces CE Mark Approval for Angel(R) cPRP System for Processing Blood and Bone Marrow Aspirate
Regenerative Medicine Orthopaedic Regulatory

HSMN NewsFeed - 8 Nov 2012
Angel(R) cPRP System Granted FDA 510(K) Clearance for Processing Blood and Bone Marrow Aspirate
Devices Regenerative Medicine Orthopaedic FDA

HSMN NewsFeed - 7 Nov 2012
URGENT NOTICE -- DRUG RECALL: Boehringer Ingelheim Pharmaceuticals, Inc. Initiates a Voluntary Recall of a Single Manufacturing Lot of Pradaxa(R) (dabigatran etexilate mesylate) Capsules 75mg in the U.S. and Puerto Rico
Biopharmaceuticals Cardiology Product Recall

HSMN NewsFeed - 23 Oct 2012
Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami
Devices Interventional Cardiology

HSMN NewsFeed - 26 Aug 2012
Boston Scientific WATCHMAN(R) Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use
Devices Interventional Regulatory

HSMN NewsFeed - 22 Aug 2012
Penumbra Inc. Launches New 5MAX(TM) Reperfusion Catheter for Clot Removal in Patients with Acute Ischemic Stroke
Devices Interventional Neurology

HSMN NewsFeed - 6 Aug 2012
Cytomedix Announces Medicare Coverage for Autologous PRP Gel in Chronic Wound Care
Regenerative Medicine Wound Care Reimbursement

HSMN NewsFeed - 9 Jul 2012
CartiHeal Receives Additional Funding to Prepare for Market Launch of Agili-C(TM), a Single Stage Arthroscopic Cartilage Regeneration Implant
Devices Orthopaedic Venture Capital

HSMN NewsFeed - 2 Jul 2012
Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device
Devices Cardiology

HSMN NewsFeed - 21 Jun 2012
FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review
Biopharmaceuticals FDA

HSMN NewsFeed - 24 May 2012
Stryker Announces Positive Clinical Results From The Trevo(R) Retriever System
Devices Interventional

HSMN NewsFeed - 11 May 2012
Study of First-in-Class WATCHMAN(R) Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy
Devices Interventional Cardiology

HSMN NewsFeed - 20 Mar 2012
SanBio Announces Enrollment of First Cohort of Patients in Its Clinical Trial of Stem Cell Therapy for Chronic Stroke
Regenerative Medicine Neurology

HSMN NewsFeed - 5 Mar 2012
Covidien Revascularization Device Receives FDA Clearance
Devices Interventional Neurology FDA

HSMN NewsFeed - 5 Mar 2012
diaDexus Launches PLAC(R) Test for Lp-PLA(2) Activity in Europe
Diagnostics Cardiology

HSMN NewsFeed - 30 Jan 2012
Covidien Revascularization Device Approved for Interventional Management of Stroke Trial
Devices Interventional Neurology

HSMN NewsFeed - 23 Jan 2012
European Launch Of Penumbra Separator(TM) 3D Announced At The Working Group In Interventional Neuroradiology (WIN) Seminar
Devices Interventional Radiology Neurology

HSMN NewsFeed - 18 Jan 2012
diaDexus, Inc. Names Jean-Frederic Viret, Ph.D. Chief Financial Officer
Diagnostics Personnel

HSMN NewsFeed - 3 Jan 2012
Enrollment in First MRgFUS Essential Tremor Feasibility Trial Completed
Devices Neurosurgery

HSMN NewsFeed - 29 Dec 2011
MindFrame Inc Announces CE Mark for New Capture(TM) LP Devices for Treatment of Patients Experiencing Ischemic Stroke
Devices Interventional Regulatory

HSMN NewsFeed - 23 Dec 2011
MindFrame Inc. Launches Registry to Improve Quality of Care for Patients Experiencing Ischemic Stroke
Devices Neurology

HSMN NewsFeed - 19 Dec 2011
Cerevast Therapeutics Receives CE Mark for Clotbust ER� Ultrasound Stroke Treatment Device
Devices Neurology Regulatory

HSMN NewsFeed - 16 Nov 2011
Boston Scientific's WATCHMAN(R) Device Implanted in First Patients in Latin America
Devices Cardiology

HSMN NewsFeed - 14 Nov 2011
Athersys Announces Recovery of All Rights to Cardiovascular Cell Therapy Program
Regenerative Medicine Cardiology

HSMN NewsFeed - 7 Nov 2011
Vascular Dynamics Names Former Micrus Endovascular President Robert Stern as President and CEO
Devices Personnel

HSMN NewsFeed - 25 Oct 2011
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
Biopharmaceuticals

HSMN NewsFeed - 8 Sep 2011
Concentric Medical Completes Enrollment in Prospective Multi Center Stentriever Trial for Mechanical Thrombectomy in Stroke
Devices Neurology Interventional

HSMN NewsFeed - 31 Aug 2011
STRYKER Signs Definitive Agreement to Acquire CONCENTRIC MEDICAL, Inc.
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 26 Aug 2011
Boehringer Ingelheim to Launch RE-ALIGN Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Jul 2011
Initiation of Penumbra, Inc.�s THERAPY Trial Announced at the Society of NeuroInterventional Surgery�s 8th Annual Meeting in Colorado Springs, CO
Devices Neurology Interventional

HSMN NewsFeed - 17 Jun 2011
Penumbra, Inc. Receives Shonin Approval for the Penumbra System(R) in Japan for Use in the Revascularization of Patients with Acute Ischemic Stroke
Devices Interventional Neurosurgery Regulatory

HSMN NewsFeed - 5 Apr 2011
Reverse Medical Corporation Receives CE Mark Approval for the ReFlex(TM) A+ Catheter for Intracranial Distal Access and Aspiration
Devices Neurology Interventional Regulatory

HSMN NewsFeed - 17 Feb 2011
Stemedica Receives Approval From UCSD to Initiate Ischemic Stroke Study With Adult Allogeneic Stem Cells
Biopharmaceuticals Regenerative Medicine Neurology

HSMN NewsFeed - 9 Feb 2011
Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial
Devices Neurology Interventional

HSMN NewsFeed - 25 Jan 2011
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
Biopharmaceuticals Cardiology Generics FDA

HSMN NewsFeed - 19 Jan 2011
Boston Scientific to Acquire Atritech
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 3 Jan 2011
Stryker Completes Acquisition of the Neurovascular Division of Boston Scientific
Devices Neurology Interventional Acquisitions

HSMN NewsFeed - 1 Nov 2010
Penumbra, Inc. Enrolls First Patients In PULSE Clinical Trial To Evaluate A Fully Retrievable, Dense Mesh Temporary Stent For Immediate Flow Restoration In Interventional Acute Ischemic Stroke Treatment
Devices Interventional Neurology

HSMN NewsFeed - 20 Oct 2010
FDA Approves Pradaxa, Marking a Major Milestone to Reduce the Risk of Stroke in Patients with Non-Valvular Atrial Fibrillation
Biopharmaceuticals Cardiology Neurology FDA

HSMN NewsFeed - 15 Oct 2010
Aldagen Announces Appointment of Lyle A. Hohnke, Ph.D. as Chief Executive Officer
Regenerative Medicine Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Sep 2010
Concentric Medical Announces Initiation of the First Stentriever Study in Europe
Devices Neurology Interventional

HSMN NewsFeed - 21 Sep 2010
Athersys Receives Orphan Drug Designation for MultiStem in Graft vs. Host Disease
Regenerative Medicine FDA

HSMN NewsFeed - 20 Sep 2010
Athersys Announces Groundbreaking Data Showing Neuroprotective Effects of MultiStem Therapy for Traumatic Brain Injury
Regenerative Medicine Neurology

HSMN NewsFeed - 28 Jul 2010
VaxGen and diaDexus Complete Merger
Diagnostics Cardiology Mergers & Acquisitions

HSMN NewsFeed - 21 Jul 2010
Concentric Medical Announces First Stroke Patients Treated With the Merci Retriever(R) in Japan
Devices Neurology

HSMN NewsFeed - 12 Jul 2010
Johnson & Johnson Announces Definitive Agreement to Acquire Micrus Endovascular
Devices Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 17 Jun 2010
Micrus Endovascular Receives Approval to Market DeltaPaq and DeltaPlush Microcoils in Japan
Devices Interventional Neurology Regulatory

HSMN NewsFeed - 2 Jun 2010
Concentric Medical Announces CE Mark of Aspiration Indication for the DAC(TM) Family of Neurovascular Catheters
Devices Neurology Interventional Regulatory

HSMN NewsFeed - 26 May 2010
The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery
Devices Interventional

HSMN NewsFeed - 21 May 2010
Endologix Appoints Thomas C. Wilder to its Board of Directors
Devices Personnel

HSMN NewsFeed - 30 Mar 2010
Reverse Medical Corporation Successfully Completes Series B Financing
Devices Interventional Venture Capital

HSMN NewsFeed - 19 Mar 2010
Stemedica Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic Mesenchymal Stem Cells
Regenerative Medicine Neurology

HSMN NewsFeed - 23 Feb 2010
Aldagen Announces Strategic Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Feb 2010
CoAxia Announces Completion of Enrollment in Ischemic Stroke Trial
Devices Interventional Neurology

HSMN NewsFeed - 10 Feb 2010
Concentric Medical Announces Key International Regulatory Approvals of Its Trevo(TM) System
Devices Interventional Neurology Regulatory

HSMN NewsFeed - 8 Feb 2010
Banyan Biomarkers Announces New Chief Executive Officer
Diagnostics Neurology Personnel

HSMN NewsFeed - 12 Jan 2010
Concentric Medical Announces First Patients Treated With Trevo(TM) System in Acute Ischemic Stroke
Devices Neurology Interventional

HSMN NewsFeed - 11 Jan 2010
Interim Study Data Indicate Improved Blood Pressure Management With Cardene(R) I.V. Compared to Labetalol in Patients with Acute Stoke
Biopharmaceuticals Cardiology Neurology

HSMN NewsFeed - 21 Oct 2009
The Interventional Management of Stroke (IMS) III Trial Protocol Now Includes The Penumbra System, An Aspiration-Based Thrombectomy Device for Interventional Debulking and Removal of Cerebral Clots in Acute Stroke Patients
Devices Interventional Radiology Neurology

HSMN NewsFeed - 7 Oct 2009
Reverse Medical Corporation Achieves Milestone of Human Use with the ReStore(TM) Microcatheter in Acute Ischemic Stroke
Devices Interventional Neurology

HSMN NewsFeed - 7 Oct 2009
Penumbra, Inc. Enrolls First Patient in the START Clinical Trial to Define Image Guided Patient Selection Criteria for Interventional Acute Ischemic Stroke Treatment
Devices Interventional Radiology Neurosurgery Neurology

HSMN NewsFeed - 23 Sep 2009
Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine

HSMN NewsFeed - 22 Sep 2009
Concentric Medical Launches Full Family of DAC(TM) Neurovascular Catheters
Devices Interventional Neurology

HSMN NewsFeed - 21 Sep 2009
Invatec Announces the Worldwide Launch of FiberNet�, the Smallest Distal Embolic Protection System on the Market, at CIRSE 2009
Devices Interventional

HSMN NewsFeed - 10 Sep 2009
Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine

HSMN NewsFeed - 8 Sep 2009
IMRIS receives FDA clearance for IMRISNV and IMRIScardio
Devices Radiology Cardiology Neurology FDA

HSMN NewsFeed - 27 Aug 2009
NeuroVasx Receives Canadian Approval for cPAX Aneurysm Treatment System
Devices Interventional Neurology Regulatory

HSMN NewsFeed - 24 Aug 2009
Micrus Endovascular Signs Licensing and Development Agreement for Flow Diversion Technology
Devices Neurology Interventional

HSMN NewsFeed - 21 Aug 2009
Stemedica Requests Pre-IND Meeting With FDA
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 23 Jul 2009
Micrus Endovascular Announces Positive DeltaPaq Microcoil Study Results
Devices Neurology Interventional

HSMN NewsFeed - 21 Jul 2009
Stem Cell Therapeutics Corp. Receives Green Light to Begin Enrolling Patients in the India Phase IIb Acute Ischemic Stroke Trial
Regenerative Medicine Neurology

HSMN NewsFeed - 24 Jun 2009
Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
Devices Monitoring Cardiology Neurology

HSMN NewsFeed - 22 Jun 2009
CoAxia, Inc. Announces $21.5M Series D Financing
Devices Neurology Venture Capital

HSMN NewsFeed - 16 Jun 2009
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
Regenerative Medicine

HSMN NewsFeed - 12 Jun 2009
Abbott Announces Launch of Next-Generation Embolic Protection System
Devices Interventional

HSMN NewsFeed - 14 May 2009
Control Medical Closes Series A Financing with Strategic Investors
Devices Surgery Venture Capital

HSMN NewsFeed - 14 May 2009
Concentric Medical Announces Enrollment Milestone for Merci Registry
Devices Interventional Neurology

HSMN NewsFeed - 30 Apr 2009
PhotoThera Closes $50 Million Financing, Announces New President and Chief Executive Officer
Devices Neurology Venture Capital Personnel

HSMN NewsFeed - 13 Apr 2009
Transoma Medical Announces First Patient Enrollment in Clinical Study on Long-Term Cardiac Monitoring for Detection of Atrial Fibrillation after Cryptogenic Stroke
Devices Cardiology Monitoring

HSMN NewsFeed - 31 Mar 2009
Boehringer Ingelheim Plans to Launch U.S. Registry to Assess the State of Anticoagulation Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Biopharmaceuticals Cardiology

HSMN NewsFeed - 25 Mar 2009
NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
Devices Neurology Interventional Regulatory

HSMN NewsFeed - 25 Mar 2009
Top Neurology Programs Control Fever with Arctic Sun Cooling Technology
Devices Neurology

HSMN NewsFeed - 12 Mar 2009
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 20 Feb 2009
Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009
Devices Neurology

HSMN NewsFeed - 4 Feb 2009
Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jan 2009
Concentric Medical Reaches Important Stroke Milestone
Devices Neurology Interventional

HSMN NewsFeed - 8 Jan 2009
New Clinical Studies Support Broader Use of CardioNet System for the Detection of Atrial Fibrillation
Devices Cardiology

HSMN NewsFeed - 8 Jan 2009
Concentric Medical Closes on $15 Million Financing
Devices Interventional Venture Capital

HSMN NewsFeed - 18 Dec 2008
Boston Scientific Initiates Carotid Stent Clinical Study
Devices Interventional

HSMN NewsFeed - 15 Dec 2008
Cardium's InnerCool Awarded U.S. Supplier Agreement With Novation LLC
Devices Group Purchasing

HSMN NewsFeed - 20 Oct 2008
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
Devices FDA

HSMN NewsFeed - 20 Oct 2008
Concentric Medical Launches Distal Access Catheter
Devices Interventional

HSMN NewsFeed - 25 Sep 2008
Recent Research Shows Significant Benefits in Acute Ischaemic Stroke With Actilyse(R) Beyond Currently Approved Three Hour Treatment Window
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Sep 2008
ImaRx Therapeutics Divests Urokinase Franchise to Microbix Biosystems
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 23 Sep 2008
Micrus Endovascular Announces Launch of Innovative DeltaPaq Microcoil System
Devices Interventional Neurology

HSMN NewsFeed - 18 Sep 2008
Stem Cell Therapeutics Corp. Receives Letter From Health Canada and Verbal Request From FDA to Place a Clinical Hold on Its REGENESIS Phase IIb Stroke Trial in Canada and the US, Respectively
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 16 Sep 2008
Micrus Endovascular Launches Neuropath Guide Catheter
Devices Neurology Interventional

HSMN NewsFeed - 12 Sep 2008
OmniSonics Medical Technologies Announces Licensing and Development Agreement with Boston Scientific
Devices Interventional Licensing

HSMN NewsFeed - 9 Sep 2008
Brigham and Women's Hospital and Celera Publish Results Demonstrating That Carriers of a Variant of the LPA Gene Have More Than Two-Fold Higher Risk of Major Cardiovascular Events and That This Risk is Eliminated by Aspirin Therapy
Cardiology

HSMN NewsFeed - 2 Sep 2008
Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib
Devices Cardiology

HSMN NewsFeed - 13 Aug 2008
Brainsgate Closes $27.5M Round Led by Johnson & Johnson Development Corporation (JJDC), Joined by Agate Medical Investments
Devices Neurology Venture Capital

HSMN NewsFeed - 4 Aug 2008
Pluristem Appoints Ms. Chaya Mazouz Clinical Operations Director
Regenerative Medicine Personnel

HSMN NewsFeed - 28 Jul 2008
Concentric Medical Launches Next Generation Family of Neurovascular Retrievers
Devices Interventional Neurology

HSMN NewsFeed - 17 Jul 2008
Merck to Fund U.S. VIOXX(R) Product Liability Resolution Program
Biopharmaceuticals Litigation

HSMN NewsFeed - 14 Jul 2008
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
Devices Regulatory

HSMN NewsFeed - 14 Jul 2008
Micrus Endovascular Receives FDA Approval for Intracranial Stent Clinical Trial
Devices Neurology Interventional FDA

HSMN NewsFeed - 10 Jul 2008
Micrus Endovascular Receives Approval to Market Cerecyte Microcoils in Japan
Devices Regulatory Neurology Interventional

HSMN NewsFeed - 7 Jul 2008
Neurobiological Technologies' CEO to Retire on December 31, 2008
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 23 Jun 2008
Micrus Endovascular Announces CE Mark for PHAROS Vitesse Stent
Devices Neurology Interventional Regulatory

HSMN NewsFeed - 5 Jun 2008
Positive Clinical Data Evaluating the Micrus Endovascular Cerecyte Microcoil Published in Peer-Reviewed Journals
Devices Neurosurgery Interventional

HSMN NewsFeed - 30 May 2008
Merck Wins Appeal of First VIOXX(R) Case to go to Trial
Biopharmaceuticals Litigation

HSMN NewsFeed - 30 May 2008
Stem Cell Therapeutics Corp. Expands Executive Team by Appointing Thomas Franck as Vice President of Commercial Planning
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 29 May 2008
Merck Wins Appeal of First VIOXX(R) Case to go to Trial
Biopharmaceuticals Litigation

HSMN NewsFeed - 15 May 2008
Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
Neurology

HSMN NewsFeed - 5 May 2008
Gore Receives Approval From FDA For Unique Patent Foramen Ovale Stroke Study
Devices Cardiology FDA

HSMN NewsFeed - 29 Apr 2008
Cardium Reports on Science Channel Series Featuring InnerCool's Endovascular Cooling During Brain Surgery at Stanford University
Devices Neurosurgery

HSMN NewsFeed - 23 Apr 2008
Stem Cell Therapeutics Corp. Receives "May Proceed" From FDA for Its Phase IIb Clinical Stroke Trial and IND
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 23 Apr 2008
Micrus Endovascular and Chemence Medical Products Sign Development Agreement for Liquid Embolic Products
Devices Neurology Interventional

HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology

HSMN NewsFeed - 11 Apr 2008
Maria Sainz Named President and CEO of Concentric Medical
Devices Personnel

HSMN NewsFeed - 19 Mar 2008
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Devices Distribution

HSMN NewsFeed - 17 Mar 2008
Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
Biopharmaceuticals

HSMN NewsFeed - 5 Mar 2008
New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 4 Mar 2008
Pluristem Submits Pre-IND Application in Germany to Initiate Clinical Trials of PLX-PAD for Peripheral Artery Disease
Regenerative Medicine Regulatory

HSMN NewsFeed - 20 Feb 2008
Stem Cell Therapeutics Announces Favorable Results From the Phase IIa BETAS Stroke Trial
Regenerative Medicine Neurology

HSMN NewsFeed - 20 Feb 2008
Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Feb 2008
diaDexus Receives FDA Clearance for Automated Blood Test That Identifies Stroke & Heart Attack Risk
DIagnostics Cardiology FDA

HSMN NewsFeed - 15 Feb 2008
Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding
Devices Interventional Neurology Personnel

HSMN NewsFeed - 30 Jan 2008
ImaRx Therapeutics Transitions Business Strategy
Biopharmaceuticals

HSMN NewsFeed - 28 Jan 2008
Concentric Medical Announces European Release of Expanded Family of Neurovascular Retrievers for use in Stroke Patients
Devices Neurology Interventional

HSMN NewsFeed - 17 Jan 2008
Micrus Endovascular and Genesis Medical Interventional Sign License, Development and Commercialization Agreement
Devices Interventional Neurology Licensing

HSMN NewsFeed - 7 Jan 2008
Penumbra, Inc. Announces 510(k) Clearance of the Penumbra System(TM) for Use in the Revascularization of Patients With Acute Ischemic Stroke
Devices Neurology Interventional FDA

HSMN NewsFeed - 4 Jan 2008
ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Dec 2007
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
Regenerative Medicine Cardiology

HSMN NewsFeed - 12 Dec 2007
Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
Biopharmaceuticals Neurology Interventional

HSMN NewsFeed - 6 Dec 2007
Micrus Endovascular Receives Approval to Market Stretch-Resistant Microcoils in Japan
Devices Neurology Interventional Regulatory

HSMN NewsFeed - 28 Nov 2007
Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Nov 2007
PAION is Seeking a New US-Partner for Desmoteplase
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Nov 2007
Micrus Endovascular Names Gordon Sangster Chief Financial Officer
Devices Personnel

HSMN NewsFeed - 5 Nov 2007
Merit Medical to Acquire Cardiac and Peripheral Assets From Micrus Endovascular
Devices Interventional Acquisitions

HSMN NewsFeed - 5 Nov 2007
ImaRx Therapeutics and Philips to Collaborate on Potential Treatment for Ischemic Stroke Using Microbubbles and Ultrasound
Devices Biopharmaceuticals Neurology

HSMN NewsFeed - 5 Nov 2007
Micrus Endovascular to Divest $3 Million in Non-Core Cardiac and Peripheral Assets to Merit Medical Systems
Devices Interventional

HSMN NewsFeed - 25 Oct 2007
Minnesota Based Lumen Biomedical Goes Global with Innovative Products for Patients with Vascular Disease
Devices Interventional

HSMN NewsFeed - 22 Oct 2007
InnerCool Licenses New Therapeutic for Potential Use in Stroke Patients
Devices Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 22 Oct 2007
Schering-Plough Reports Two Phase II Studies of Thrombin Receptor Antagonist (TRA) Build on Findings from Previous Phase II Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 15 Oct 2007
Improved Perioperative Blood Pressure Control Associated with Reduced Risk of Kidney Dysfunction in Cardiac Surgery Patients
Biopharmaceuticals Cardiology Surgery

HSMN NewsFeed - 27 Sep 2007
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 24 Sep 2007
Micrus Endovascular Board of Directors Names CEO John Kilcoyne Chairman and Promotes Robert Stern to President
Devices Personnel

HSMN NewsFeed - 5 Sep 2007
Athersys Elects Jeff Randall to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Sep 2007
Athersys Announces Completion of Name Change and New Ticker Symbol, AHYS
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2007
Penumbra, Inc. Completes Pivotal Stroke Trial of Intracranial Revascularization
Devices Interventional Radiology Neurology

HSMN NewsFeed - 29 Aug 2007
Concentric Medical Announces Regulatory Clearance of Newest Neurovascular Retriever for Use in Stroke Patients
Devices Interventional Neurology FDA

HSMN NewsFeed - 28 Aug 2007
ImaRx Therapeutics Receives DSMB Approval to Proceed with Second Dose Cohort in TUCSON Trial of SonoLysis(TM) + tPA Therapy in Acute Ischemic Stroke
Biopharmaceuticals Neurology

HSMN NewsFeed - 22 Aug 2007
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Biopharmaceuticals

HSMN NewsFeed - 31 Jul 2007
Micrus Endovascular Signs Letter of Intent to Acquire Revascularization Technology to Treat Ischemic Stroke
Devices Interventional Neurology

HSMN NewsFeed - 16 Jul 2007
Concentric Medical Enrolls First Five Patients in Landmark Ischemic Stroke Registry
Devices Neurology Interventional

HSMN NewsFeed - 12 Jul 2007
Barr Confirms Patent Challenge of Aggrenox(R)
Biopharmaceuticals Generics

HSMN NewsFeed - 5 Jul 2007
Study Shows Lp-PLA2 Identifies Individuals at Highest Risk for Ischemic Stroke
Diagnostics Neurology

HSMN NewsFeed - 26 Jun 2007
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2007
EKOS Appoints Robert Hubert as President and Chief Executive Officer
Devices Drug Delivery Personnel

HSMN NewsFeed - 18 Jun 2007
NeuroVasx, Inc. Announces 510(k) FDA Submission of its cPAX Aneurysm Treatment System(TM) for Treatment of Cerebral Aneurysms
Devices Interventional Neurology

HSMN NewsFeed - 5 Jun 2007
Concentric Medical Launches Two New Small Vessel Neurovascular Retrievers for Use in Stroke Patients
Devices Interventional Neuology

HSMN NewsFeed - 5 Jun 2007
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 31 May 2007
Topline Results of Phase III Study in Acute Ischemic Stroke (Dias-2) Do Not Demonstrate Difference Between Desmoteplase and Placebo
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 May 2007
CoAxia(TM) Announces First Patients Enrolled in Study Extending Treatment for Acute Stroke Up to 24 Hours
Devices Neurology Interventional

HSMN NewsFeed - 3 May 2007
diaDexus Appoints Charles Patrick to Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 1 May 2007
diaDexus Announces Two Key Executive Appointments
Diagnostics Personnel

HSMN NewsFeed - 26 Apr 2007
Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds
Biopharmaceuticals

HSMN NewsFeed - 20 Apr 2007
The Lancet Publishes PREVAIL Study Results Showing Lovenox(R) Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
Biopharmaceuticals

HSMN NewsFeed - 18 Apr 2007
Schering-Plough Announces Initiation of Two Phase III Clinical Trials for Novel Selective Antiplatelet Therapy (TRA-SCH 530348)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Mar 2007
Pivotal Phase III Findings With Investigational Drug Cleviprex(TM) (Clevidipine) Demonstrate Perioperative Blood Pressure Control In Cardiac Surgery
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Mar 2007
Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Mar 2007
Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
Devices Interventional

HSMN NewsFeed - 25 Mar 2007
Data Shows That Omission of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Medical Patients Is Frequent and Leads to Higher Risk of Deep-Vein Thrombosis (DVT)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 24 Mar 2007
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Mar 2007
First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack
Devices Cardiology

HSMN NewsFeed - 16 Mar 2007
Diffusion Pharmaceuticals Initiates Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
Biopharmaceuticals

HSMN NewsFeed - 5 Feb 2007
Cardium and InnerCool Announce New External and Internal Patient Temperature Modulation Systems
Devices

HSMN NewsFeed - 5 Feb 2007
Merci(R) L5 Retriever from Concentric Medical Receives FDA Clearance for Neurovascular Clot Retrieval in Stroke Patients
Devices Interventional Neurology FDA

HSMN NewsFeed - 24 Jan 2007
ev3 Inc. Announces US FDA Approval of PROTEGE(R) RX Carotid Stent
Devices Interventional FDA

HSMN NewsFeed - 24 Jan 2007
Proneuron Announces the Receipt of a $430,000 Grant from the Michael J. Fox Foundation to Develop Its PN277 for the Treatment of Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 Jan 2007
D-Pharm Announces Positive Phase IIb Trial Results for DP-b99 in Acute Stroke Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Dec 2006
Nonsurgical Treatment for Arteriovenous Malformations
Devices Interventional Neurology Radiology

HSMN NewsFeed - 13 Dec 2006
CoAxia(TM) Announces FDA Approval of Clinical Trial for Its Novel Stroke Treatment in Patients up to 24 Hours After Onset
Devices Neurology Interventional FDA

HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals

HSMN NewsFeed - 12 Dec 2006
New Study Shows Clexane(R) / Lovenox(R) (Enoxaparin Sodium Injection) is More Effective Than Unfractionated Heparin (UFH) for Preventing the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke
Biopharmaceuticals

HSMN NewsFeed - 12 Dec 2006
New Study Shows Lovenox(R) (Enoxaparin Sodium Injection) Is More Effective Than Unfractionated Heparin (UFH) for Lowering the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke
Biopharmaceuticals

HSMN NewsFeed - 7 Dec 2006
New Billing Code and Medicare Payment Recommendation Issued for Lp-PLA2 Testing
Diagnostics Cardiology Reimbursement

HSMN NewsFeed - 1 Dec 2006
Micrus Endovascular Acquires Catheter Technology Company VasCon LLC
Devices Mergers & Acquisitions

HSMN NewsFeed - 17 Nov 2006
Celtic Pharma and Neurobiological Technologies Present an Update on XERECEPT(R) for Peritumoral Brain Edema at the 11th Annual Meeting of the Society for Neuro-Oncology
Biopharmaceuticals Oncology Neurology

HSMN NewsFeed - 14 Nov 2006
Studies Presented at AHA Confirm Role of Inflammatory Marker Lp-PLA2 in Assessing Cardiovascular Risk and in Secondary Prevention
Diagnostics Cardiology

HSMN NewsFeed - 9 Nov 2006
Neurobiological Technologies, Inc. Comments on Recent Stroke Trial Developments
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Nov 2006
diaDexus Reports Study Showing Lp-PLA2 Is an Independent Marker of Coronary Artery Disease and Death
Diagnostics Cardiology

HSMN NewsFeed - 27 Oct 2006
Patient Recruitment to Resume Without Modification of Protocol for Desmoteplase Phase IIB/III Stroke Study DIAS-2
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Oct 2006
NXY-059 Does Not Meet Efficacy Endpoints in Phase III Trial for Acute Ischemic Stroke
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Oct 2006
Cardium Reports on Positive Effects of Hypothermia Following Heart Attack and Announces Clinical Study to Be Co-Sponsored by Swedish Cardiology Center
Devices Interventional Cardiology

HSMN NewsFeed - 24 Oct 2006
Study Shows Inflammatory Enzyme Lp-PLA2 Predicts Recurrent Stroke
Diagnostics Cardiology Neurology

HSMN NewsFeed - 21 Sep 2006
Dr. Michael Morgan Reports on Benefits of InnerCool's Celsius Control System in Inducing Hypothermia During Aneurysm Surgery
Devices Neurosurgery

HSMN NewsFeed - 21 Sep 2006
Panacea Pharmaceuticals Announces Appointments of Christine L. Brauer, Ph.D. as Vice President, Regulatory Affairs; and Jefferey Jones, M.S., as Director of Quality
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Sep 2006
St. Joseph's Hospital Selected as First Upper Midwest Site to Host Patient Trials of New Stroke Device
Devices Interventional Neurology

HSMN NewsFeed - 7 Sep 2006
European commission expands indication for PLAVIX� (clopidogrel bisulfate) offering new option for patients with most severe type of heart attack
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 5 Sep 2006
Nuvelo Announces Completion of Patient Enrollment in SONOMA-2, First Phase 3 Trial of Alfimeprase in Central Venous Catheter Occlusion
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2006
Nuvelo Announces Completion of Patient Enrollment in NAPA-2, First Phase 3 Trial of Alfimeprase in Acute Peripheral Arterial Occlusion
Biopharmaceuticals

HSMN NewsFeed - 24 Aug 2006
Neurobiological Technologies, Inc. Announces Completion of Targeted U.S. Site Selection for Its First Viprinex(TM) (Ancrod Injection) Phase III Clinical Trial for Acute Ischemic Stroke

HSMN NewsFeed - 17 Aug 2006
FDA Approves New Indication for PLAVIX(R) (clopidogrel bisulfate) Offering New Option for Patients With Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 9 Aug 2006
Pfizer's Lipitor Shown to Reduce the Chance of Additional Strokes in Stroke Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Aug 2006
Panel Recommends Values for Lp-PLA2 in the Assessment of Cardiovascular Disease Risk
Diagnostics Cardiology

HSMN NewsFeed - 6 Jul 2006
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
Biopharmaceuticals

HSMN NewsFeed - 28 Jun 2006
Panacea Pharmaceuticals Announces Appointment of Stephen N. Keith, MD, MSPH as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2006
New Data Published in an American Heart Association Journal Shows That Lipoprotein-Associated Phospholipase A2 Independently Adds to the Diagnostic Accuracy of Traditional Risk Assessment for Future Cardiovascular Events
Diagnostics Cardiology

HSMN NewsFeed - 15 Jun 2006
Neurobiological Technologies Announces Departure of Jonathan Wolter as Vice President and Chief Financial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 30 May 2006
Neurobiological Technologies Inc. Appoints David C. Chou to Oversee Chemistry, Manufacturing and Controls (CMC)
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 May 2006
New Stroke Guidelines Underscore Importance of Aspirin for Women
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 May 2006
Renovis Names Donald R. Joseph as Senior Vice President, Corporate Development and General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2006
Merck Announces Preliminary Analyses of Off-Drug Extension of APPROVe Study
Biopharmaceuticals Oncology Cardiology

HSMN NewsFeed - 19 Apr 2006
FDA Grants Fast Track Designation to Schering-Plough for its Thrombin Receptor Antagonist SCH 530348
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 6 Apr 2006
PhotoThera Inc. Announces New President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 22 Mar 2006
Neurobiological Technologies Inc. Announces Initiation of Second Viprinex(TM) (Ancrod) Phase III Clinical Trial for Acute Ischemic Stroke
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Mar 2006
Headline Results From CHANT Safety and Tolerability Study In Intracerebral Hemorrhage (ICH) Show NXY-059 Achieved Key Endpoints
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Mar 2006
Renovis Announces That Headline Results From CHANT Safety and Tolerability Trial in Intracerebral Hemorrhage (ICH) Show NXY-059 Achieved Key Endpoints
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Mar 2006
New Study Furthers Understanding of the Role of Dual Antiplatelet Therapy in the Prevention Of Atherothrombotic Events, Including Heart Attack, Stroke or Cardiovascular Death in Broad Population
Biopharmaceuticals Cardiology

HSMN NewsFeed - 9 Mar 2006
Cardium Acquires InnerCool Therapies, a Leading Provider of FDA-Cleared Therapeutic Hypothermia Systems
Devices Mergers & Acquisitions

HSMN NewsFeed - 27 Feb 2006
Nuvelo and Bayer HealthCare Begin SONOMA-3, Second Phase 3 Trial of Alfimeprase in Patients With Central Venous Catheter Occlusion
Biopharmaceuticals

HSMN NewsFeed - 16 Feb 2006
New Clinical Data Points to Promising Treatment for Ischemic Stroke
Devices Neurology Interventional

HSMN NewsFeed - 8 Feb 2006
New England Journal of Medicine Publishes NXY-059 Study, the First International Study of a Neuroprotectant to Show Reduced Disability Following Acute Ischemic Stroke
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Jan 2006
New Study Shows That Elevated Lp-PLA2 Signals Early Endothelial Dysfunction, a Marker of Atherosclerosis, in Humans
Diagnostics Cardiology

HSMN NewsFeed - 18 Jan 2006
FDA Grants Priority Review to PLAVIX(R) (Clopidogrel Bisulfate) Supplemental New Drug Application (sNDA) for Additional Type of Heart Attack
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 9 Jan 2006
Micrus Endovascular and BIOTRONIK AG Sign Development and Distribution Agreement
Devices Interventional Distribution

Return to NewsFeed

Additional items found! 94

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 94 additional stories matching:
ischemic stroke
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.